Current Edition

Driving the Commercialisation of Regenerative Medicine

With more than 7000 distinct types of rare and genetic diseases and 400+ million individuals suffering from a rare disease, regenerative medicine holds the hope for a cure – transforming healthcare by revolutionising patient care from conventional treatment models to curative therapy models. Colin Coffua of EVERSANA discusses how the promise of regenerative medicine becomes a reality for the millions of patients who deserve it.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/07/Driving-the-Commercialisation-of-Regenerative-Medicine.pdf”]